View in EDS

Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program.

Saved in:
Bibliographic Details
Title: Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program.
Authors: Rowe CL; Division of Epidemiology, School of Public Health, University of California, Berkeley, 2121 Berkeley Way, Floor 5, Berkeley, CA 94704, USA; Center on Substance Use and Health, San Francisco Department of Public Health, 25 Van Ness, Suite 500, San Francisco, CA 94102, USA. Electronic address: chrisrowe@berkeley.edu., Ahern J; Division of Epidemiology, School of Public Health, University of California, Berkeley, 2121 Berkeley Way, Floor 5, Berkeley, CA 94704, USA., Hubbard A; Division of Biostatistics, School of Public Health, University of California, Berkeley, 2121 Berkeley Way, Floor 5, Berkeley, CA 94704, USA., Coffin PO; Center on Substance Use and Health, San Francisco Department of Public Health, 25 Van Ness, Suite 500, San Francisco, CA 94102, USA; Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, 533 Parnassus Ave, San Francisco, CA 94143, USA.
Source: Journal of substance abuse treatment [J Subst Abuse Treat] 2022 Jan; Vol. 132, pp. 108452. Date of Electronic Publication: 2021 Apr 30.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Pergamon Press Country of Publication: United States NLM ID: 8500909 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-6483 (Electronic) Linking ISSN: 07405472 NLM ISO Abbreviation: J Subst Abuse Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34098203
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rowe+CL%22">Rowe CL</searchLink>; Division of Epidemiology, School of Public Health, University of California, Berkeley, 2121 Berkeley Way, Floor 5, Berkeley, CA 94704, USA; Center on Substance Use and Health, San Francisco Department of Public Health, 25 Van Ness, Suite 500, San Francisco, CA 94102, USA. Electronic address: chrisrowe@berkeley.edu.<br /><searchLink fieldCode="AU" term="%22Ahern+J%22">Ahern J</searchLink>; Division of Epidemiology, School of Public Health, University of California, Berkeley, 2121 Berkeley Way, Floor 5, Berkeley, CA 94704, USA.<br /><searchLink fieldCode="AU" term="%22Hubbard+A%22">Hubbard A</searchLink>; Division of Biostatistics, School of Public Health, University of California, Berkeley, 2121 Berkeley Way, Floor 5, Berkeley, CA 94704, USA.<br /><searchLink fieldCode="AU" term="%22Coffin+PO%22">Coffin PO</searchLink>; Center on Substance Use and Health, San Francisco Department of Public Health, 25 Van Ness, Suite 500, San Francisco, CA 94102, USA; Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, 533 Parnassus Ave, San Francisco, CA 94143, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228500909%22">Journal of substance abuse treatment</searchLink> [J Subst Abuse Treat] 2022 Jan; Vol. 132, pp. 108452. <i>Date of Electronic Publication: </i>2021 Apr 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Pergamon+Press%22">Pergamon Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8500909 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-6483 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2207405472%22">07405472 </searchLink><i>NLM ISO Abbreviation: </i>J Subst Abuse Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34098203
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jsat.2021.108452
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 108452
    Titles:
      – TitleFull: Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rowe CL
      – PersonEntity:
          Name:
            NameFull: Ahern J
      – PersonEntity:
          Name:
            NameFull: Hubbard A
      – PersonEntity:
          Name:
            NameFull: Coffin PO
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2022 Jan
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1873-6483
          Numbering:
            – Type: volume
              Value: 132
          Titles:
            – TitleFull: Journal of substance abuse treatment
              Type: main
ResultId 1